Related Experiment Video
Updated: Aug 8, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
The Gulf Chronic Total Occlusion Registry: Short- and Long-Term Outcomes Across Management Strategies
Amin Daoulah1, Mokhtar Abdirahman Kahin2, Prashanth Panduranga3
1Department of Cardiovascular Medicine, King Faisal Specialist Hospital & Research Center, Jeddah, Kingdom of Saudi Arabia.
Insights
For chronic total occlusion (CTO), neither percutaneous coronary intervention (PCI) nor coronary artery bypass grafting (CABG) showed superiority over medical therapy for hard cardiovascular outcomes. However, revascularization, especially CABG, significantly reduced angina burden.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Chronic total occlusion (CTO) significantly increases ischemic burden, heart failure, and mortality.
- Comparative outcomes of medical therapy, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG) for CTO are not well-established.
Purpose of the Study:
- To compare the clinical outcomes of medical therapy, PCI, and CABG in patients diagnosed with CTO.
- To evaluate hard cardiovascular endpoints and angina burden across different treatment strategies.
Main Methods:
- Analysis of 741 patients with angiographically confirmed CTO across 7 centers in 4 Gulf countries (2021-2023).
- Patients were managed with medical therapy (n=151), PCI (n=441), or CABG (n=149).
- Primary in-hospital endpoint: major adverse cardiovascular events (MACE). Long-term endpoint: major adverse cardiac and cerebrovascular events (MACCE)-free survival.
Main Results:
- PCI and CABG did not significantly differ from medical therapy for in-hospital MACE after adjustment.
- At a median 22-month follow-up, no significant difference in 36-month MACCE-free survival was observed between the three strategies.
- CABG was associated with a significant reduction in angina burden (Canadian Cardiovascular Society class I), while PCI showed no significant difference compared to medical therapy.
Conclusions:
- No revascularization strategy (PCI or CABG) demonstrated superiority over medical therapy for hard cardiovascular outcomes in CTO patients.
- Revascularization, particularly CABG, was associated with a significant improvement in angina symptoms at follow-up.
- Treatment decisions for CTO should consider both hard outcomes and symptom relief.
Background:
Chronic total occlusion (CTO) is associated with increased ischemic burden, heart failure, and mortality. Comparative clinical outcomes associated with medical therapy, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG) remain uncertain.
Objectives:
To compare clinical outcomes associated with medical therapy, PCI, and CABG in patients with CTO.
Methods:
We analyzed 741 patients with angiographically confirmed CTO enrolled across 7 tertiary centers in 4 Gulf countries between 2021 and 2023. Patients were managed with an initial strategy of medical therapy (n = 151), PCI (n = 441), or CABG (n = 149). The primary in-hospital endpoint was major adverse cardiovascular events. The long-term endpoint was major adverse cardiac and cerebrovascular events-free survival.
Results:
Treatment allocation differed substantially by baseline clinical and angiographic risk. Medically managed patients had worse renal function, more severely reduced left ventricular ejection fraction, and more cardiogenic shock despite simpler CTO anatomy CABG patients had more extensive multivessel disease, whereas PCI patients had greater CTO lesion complexity. After adjustment, neither PCI nor CABG differed significantly from medical therapy for in-hospital major adverse cardiovascular events. At a median follow-up of 22 months, adjusted 36-month restricted mean survival time analyses showed no statistically significant difference in major adverse cardiac and cerebrovascular events-free survival between PCI, CABG, and medical therapy. Adjusted Canadian Cardiovascular Society class I at last follow-up was reached in 86.2% of medical therapy, 91.7% of PCI, and 98.0% of CABG patients; the adjusted difference vs medical therapy was significant for CABG (P < 0.001) but not for PCI P = 0.17).
Conclusions:
After adjustment, no treatment strategy demonstrated superiority for hard cardiovascular outcomes; revascularization, particularly CABG, was associated with a lower angina burden at follow-up.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Mitral Regurgitation III: Medical Management
Aneurysm III: Interprofessional Care